Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.5.4, replacing the previous v3.5.3. This signals an updated page version at the history level, with no changes to the study data.SummaryDifference0.1%

- Check20 days agoChange DetectedNew history entries were added for Contacts/Locations and Study Status with a 2026-05-04 version and a 2026-05-06 update, representing updated contact details, locations, and the study's current recruitment status in the record history.SummaryDifference0.4%

- Check27 days agoChange DetectedRevision: v3.5.3 has been added to the Study Record Versions, updating the history from v3.5.2.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.2 has been added to the history. Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed on the page. This reflects a platform version update without changes to the study record data.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history now shows a new revision entry v3.4.3 and removes the previous revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.